-transparent.png){kind=logo}
Regulation of squalene epoxidase activity was examined in rat hepatic microsomes. The hepatic squalene epoxidase activity was high in the dark period and low in the light period. Three percent cholestyramine feeding increased the hepatic squalene epoxidase activity by 2.5-fold, and the administration of lovastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, increased its activity by 2.1-fold. Co-administration of cholestyramine and lovastatin had a synergistic effect increasing the activity by 7.0-fold. On the other hand, cholesterol feeding reduced hepatic squalene epoxidase activity to 18%. The addition of sodium fluoride, a phosphatase inhibitor, and the treatment of the microsomes with ATP-Mg2+ had no effect on enzyme activity. HMG-CoA reductase activity has been reported to be regulated by cholesterol and unidentified metabolite(s) derived from mevalonate. However, since squalene epoxidase is less responsive than the reductase to the treatment with lovastatin, squalene epoxidase is thought to be regulated only by cholesterol pool.
T Satoh, and
Y Hidaka, and
T Kamei
June 1972,
The Journal of biological chemistry,
T Satoh, and
Y Hidaka, and
T Kamei
January 1985,
Methods in enzymology,
T Satoh, and
Y Hidaka, and
T Kamei
April 1970,
The Journal of biological chemistry,
T Satoh, and
Y Hidaka, and
T Kamei
September 1980,
Biochemical and biophysical research communications,
T Satoh, and
Y Hidaka, and
T Kamei
February 1975,
The Journal of biological chemistry,
T Satoh, and
Y Hidaka, and
T Kamei
May 1985,
Archives of biochemistry and biophysics,
T Satoh, and
Y Hidaka, and
T Kamei
December 1989,
Lipids,
T Satoh, and
Y Hidaka, and
T Kamei
December 1982,
Biochimica et biophysica acta,
T Satoh, and
Y Hidaka, and
T Kamei
December 1987,
Journal of lipid research,
T Satoh, and
Y Hidaka, and
T Kamei
January 1988,
Lipids,
